| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
|
|
| Synonyms | (3S,5R,10R,13R,14S,17R)- 3-[(2S,5R)- 3,5-dihydroxy- 4-methoxy- 6-methyloxan- 2-yl]oxy- 14-hydroxy- 13-methyl- 17-(5-oxo-2H-furan-3-yl)- 1,2,3,4,5,6,7,8,9,11,12,15,16,17- tetradecahydrocyclopenta[a]phenanthrene- 10-carbaldehyde |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| ECHA InfoCard | 100.013.327 |
| Chemical and physical data | |
| Formula | C30H44O9 |
| Molar mass | 548.665 g/mol |
| 3D model (Jmol) | |
|
|
|
|
|
|
|
Peruvoside (or cannogenin thevetoside) is a cardiac glycoside for heart failure.
It is derived from Cascabela thevetia (Thevetia neriifolia).